Q: SIS is down 6% after an earnings report that appears to be their best ever. Plus the following forward looking comments from Bourassa ..... " Our goal for the end of 2025 to reach approximately $1 billion of revenue and 20% adjusted EBITDA are well within our sight. " ...... Could 5i comment on the quarter and conference call with your analysis ? And possibly some insight into the stock reaction ? With optimistic forward looking statements I normally don't expect the stock price to go down ..... Thanks Garth ......
5i Research Answer:
We have comments posted now on the quarter. The goal that SIS' CEO stated has been an initiative that the company has been working towards through 'Savaria One' which it launched at the start of 2023. Savaria One is just the company's internal arm that focsues on executing strategic initiatives and setting goals like $1B in revenue. While it is optimistic, it is a goal and not necessarily direct guidance of what SIS will generate in revenue for 2025. The negative reaction was likely the result of the middling Patient care segement which contracted in Q4.